Garry Forgeson

1.2k total citations
22 papers, 918 citations indexed

About

Garry Forgeson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Garry Forgeson has authored 22 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Garry Forgeson's work include Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (3 papers) and Testicular diseases and treatments (3 papers). Garry Forgeson is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (3 papers) and Testicular diseases and treatments (3 papers). Garry Forgeson collaborates with scholars based in New Zealand, United Kingdom and Australia. Garry Forgeson's co-authors include Simon Allan, Timothy Perren, Richard Isaacs, K. Chrystal, Bridget A. Robinson, Guy A. Van Hazel, Martin R. Stockler, Niall C. Tebbutt, Michelle M. Cummins and Vinod Ganju and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and British journal of surgery.

In The Last Decade

Garry Forgeson

22 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Forgeson New Zealand 14 494 229 196 175 174 22 918
C. Bokemeyer Germany 16 268 0.5× 299 1.3× 171 0.9× 258 1.5× 121 0.7× 68 828
Alexis D. Leal United States 15 545 1.1× 128 0.6× 244 1.2× 163 0.9× 188 1.1× 57 888
Heinz Tüchler Austria 15 215 0.4× 165 0.7× 138 0.7× 96 0.5× 98 0.6× 38 868
Doğan Uncu Türkiye 15 348 0.7× 261 1.1× 80 0.4× 161 0.9× 105 0.6× 96 704
Lara Pijuán Spain 20 571 1.2× 680 3.0× 307 1.6× 168 1.0× 129 0.7× 74 1.3k
Lister Hill United States 6 556 1.1× 144 0.6× 152 0.8× 176 1.0× 84 0.5× 6 824
Yun‐Gyoo Lee South Korea 15 436 0.9× 430 1.9× 233 1.2× 112 0.6× 78 0.4× 72 942
Işıl Somali Türkiye 17 468 0.9× 215 0.9× 92 0.5× 91 0.5× 43 0.2× 51 716
H. Köppler Germany 19 382 0.8× 128 0.6× 104 0.5× 38 0.2× 297 1.7× 66 872
Marion Dhooge France 15 208 0.4× 138 0.6× 73 0.4× 145 0.8× 104 0.6× 51 581

Countries citing papers authored by Garry Forgeson

Since Specialization
Citations

This map shows the geographic impact of Garry Forgeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Forgeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Forgeson more than expected).

Fields of papers citing papers by Garry Forgeson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Forgeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Forgeson. The network helps show where Garry Forgeson may publish in the future.

Co-authorship network of co-authors of Garry Forgeson

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Forgeson. A scholar is included among the top collaborators of Garry Forgeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Forgeson. Garry Forgeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forgeson, Garry, et al.. (2019). Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service. Internal Medicine Journal. 50(3). 315–321. 4 indexed citations
2.
Broom, Reuben, Victoria Hinder, Katrina Sharples, et al.. (2014). Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial. Clinical Genitourinary Cancer. 13(1). 50–58. 34 indexed citations
3.
Simpson, Andrew, et al.. (2013). A workforce survey of New Zealand medical oncologists.. PubMed. 126(1371). 45–53. 11 indexed citations
4.
Forgeson, Garry, et al.. (2013). Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy.. PubMed. 126(1385). 76–80. 1 indexed citations
5.
Tebbutt, Niall C., Kate Wilson, Val Gebski, et al.. (2010). Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. Journal of Clinical Oncology. 28(19). 3191–3198. 315 indexed citations
6.
Colls, B M, V.J. Harvey, Chris Frampton, et al.. (1999). Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years’ experience in a national study in New Zealand. British Journal of Urology. 83(1). 76–82. 58 indexed citations
7.
Jameson, Michael B., B D Evans, Daniel H.D. Gray, et al.. (1995). Adjuvant chemotherapy for non‐metastatic osteosarcorna of the extremities in two New Zealand cancer centres. Australian and New Zealand Journal of Medicine. 25(3). 224–229. 2 indexed citations
8.
Isaacs, R., et al.. (1993). Role of computed tomography in the staging of primary breast cancer. British journal of surgery. 80(9). 1137–1137. 15 indexed citations
9.
Colls, B M, V.J. Harvey, Paul Thompson, et al.. (1992). Results of the Surveillance Policy of Stage I Non‐seminomatous Germ Cell Testicular Tumours. British Journal of Urology. 70(4). 423–428. 23 indexed citations
10.
Mitchell, Paul, et al.. (1992). Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.. PubMed. 105(929). 73–5. 5 indexed citations
11.
Selby, Peter, Pushpa Patel, S Milan, et al.. (1990). ChlVPP combination chemotherapy for Hodgkin's disease: long term results. British Journal of Cancer. 62(2). 279–285. 62 indexed citations
12.
McKeage, Mark J., B D Evans, Christopher M. Atkinson, et al.. (1990). Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group.. Journal of Clinical Oncology. 8(5). 779–783. 31 indexed citations
13.
Smith, Ian E., Timothy Perren, Sue Ashley, et al.. (1990). Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.. Journal of Clinical Oncology. 8(5). 899–905. 48 indexed citations
14.
Selby, P, S Milan, A Nandi, et al.. (1989). High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease. British Journal of Cancer. 59(4). 631–635. 44 indexed citations
15.
Gore, Martin, R Powles, A. Lakhani, et al.. (1989). Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide. Cancer Chemotherapy and Pharmacology. 23(6). 373–376. 28 indexed citations
16.
Selby, Peter J., Garry Forgeson, M Meldrum, et al.. (1988). The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studies. Hematological Oncology. 6(2). 173–179. 28 indexed citations
17.
Forgeson, Garry, et al.. (1988). Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. British Journal of Cancer. 58(4). 469–473. 46 indexed citations
18.
Weinbren, M., et al.. (1988). Unusual presentation of pseudomonas infection.. BMJ. 297(6655). 1034–1035. 1 indexed citations
19.
Powles, R, A. Lakhani, S Milan, et al.. (1988). Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.. PubMed. 3(1). 21–9. 57 indexed citations
20.
Lakhani, A., R Powles, A Nandi, et al.. (1987). Bone marrow transplantation—The Marsden experience. Hematological Oncology. 5(4). 245–254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Bokemeyer Breakdown of academic impact, for papers by Alexis D. Leal Breakdown of academic impact, for papers by Heinz Tüchler Breakdown of academic impact, for papers by Doğan Uncu Breakdown of academic impact, for papers by Lara Pijuán Breakdown of academic impact, for papers by Lister Hill Breakdown of academic impact, for papers by Yun‐Gyoo Lee Breakdown of academic impact, for papers by Işıl Somali Breakdown of academic impact, for papers by H. Köppler Breakdown of academic impact, for papers by Marion Dhooge
Rankless by CCL
2026